Friday, July 15, 2016

BRIEF-Ziopharm Oncology updates on early study for brain cancer drug

* Ziopharm issues statement regarding phase 1 study of gene

therapy candidate ad-RTS-hIL-12 in brain cancer

Read more
Posted by at

No comments:

Post a Comment

Subscribe to: Post Comments (Atom)